- Home
- RACE vs BMY Comparison
RACE vs BMY Comparison
Compare RACE & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RACE
- BMY
- Stock Information
- Founded
- RACE 1947
- BMY 1887
- Country
- RACE Italy
- BMY United States
- Employees
- RACE N/A
- BMY N/A
- Industry
- RACE Auto Manufacturing
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- RACE Consumer Discretionary
- BMY Health Care
- Exchange
- RACE Nasdaq
- BMY Nasdaq
- Market Cap
- RACE 81.7B
- BMY 97.6B
- IPO Year
- RACE 2015
- BMY N/A
- Fundamental
- Price
- RACE $491.51
- BMY $47.62
- Analyst Decision
- RACE Strong Buy
- BMY Hold
- Analyst Count
- RACE 5
- BMY 16
- Target Price
- RACE $526.25
- BMY $58.33
- AVG Volume (30 Days)
- RACE 335.1K
- BMY 14.4M
- Earning Date
- RACE 07-31-2025
- BMY 07-31-2025
- Dividend Yield
- RACE 0.70%
- BMY 5.21%
- EPS Growth
- RACE 21.86
- BMY N/A
- EPS
- RACE 9.52
- BMY 2.67
- Revenue
- RACE $7,439,244,485.00
- BMY $47,636,000,000.00
- Revenue This Year
- RACE $9.79
- BMY N/A
- Revenue Next Year
- RACE $10.85
- BMY N/A
- P/E Ratio
- RACE $50.84
- BMY $17.82
- Revenue Growth
- RACE 12.36
- BMY 4.62
- 52 Week Low
- RACE $391.54
- BMY $39.35
- 52 Week High
- RACE $509.13
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- RACE 62.87
- BMY 48.89
- Support Level
- RACE $484.87
- BMY $46.32
- Resistance Level
- RACE $494.97
- BMY $48.26
- Average True Range (ATR)
- RACE 7.58
- BMY 0.92
- MACD
- RACE 2.55
- BMY -0.02
- Stochastic Oscillator
- RACE 91.71
- BMY 31.62
About RACE Ferrari N.V.
Ferrari designs, engineers, and manufactures some of the world's most expensive luxury cars. With supply carefully controlled to be below demand and a brand steeped in decades of motor racing history, a Ferrari is viewed as a status symbol. In 2024, the company sold 13,752 vehicles at an average price over EUR 480,000 with more than 70% of its vehicles being sold to existing Ferrari clients. Eighty-six percent of revenue is generated from the sale of cars and spare parts and 10% from sponsorship, commercial, and brand activities including racing and lifestyle activities. In 2024, the Europe, Middle East, and Africa region accounted for 47% of revenue, the Americas was 33%, mainland China, Hong Kong, and Taiwan was 8%, and the rest of Asia was 12%.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.